Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance

Quest Diagnostics IncTrade
T-Rex 2X Long MSTR Daily Target ETFTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Quest Diagnostics Inc trades at $230.79 (market cap $25.48B), while T-Rex 2X Long MSTR Daily Target ETF trades at $40.57 (market cap $809.00M). The key difference: Quest Diagnostics Inc is far larger — about 31.5× T-Rex 2X Long MSTR Daily Target ETF's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while T-Rex 2X Long MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and T-Rex 2X Long MSTR Daily Target ETF for 18 Days on average.

DGXMSTU
Market Cap
$25.48B$809.00M
Volume
941,8664,577,465
Sector
HealthLeveraged / Inverse
52-Week High
$247.45$451.00
52-Week Low
$173.49$14.60
Typical Hold Time
56 Days18 Days
Enterprise Value
$31.23B—
Dividend Yield
1.49%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Quest Diagnostics Inc

Quest Diagnostics (DGX) trades at $230.76, up 1.66% today, reflecting strong year-to-date momentum driven by consistent earnings beats and growth in advanced diagnostics. The stock is near its 52-week high with a consensus price target of $250, indicating further upside potential. Recent news highlights partnerships, such as integration with Apple Health, and clinical study successes, though Medicare reimbursement cuts pose a headwind. Technical indicators show a bearish signal overall, with support at $228 and resistance at $232.

The outlook remains positive due to robust revenue growth, expanding profit margins, and strategic initiatives, but risks include regulatory pressure on lab payments and rising debt levels. Analyst sentiment is mixed, with a majority holding neutral ratings, suggesting cautious optimism amid execution challenges and market volatility.

T-Rex 2X Long MSTR Daily Target ETF

MSTU trades at $39.54, showing minimal daily movement with a 0.23% gain. The technical outlook is bearish based on moving averages, while oscillators present a neutral stance. Recent corporate actions include a 10:1 reverse stock split and a $0.29 dividend scheduled for August 2026. News coverage highlights the ETF's leveraged nature and recent volatility concerns.

The outlook remains cautious due to the bearish technical signals and leveraged ETF structure, which amplifies volatility. Investment opportunities exist for tactical traders seeking short-term momentum, but risks include daily rebalancing effects and potential value erosion during sustained market moves.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DGX

No sentiment data available yet.

MSTU
43% Buy57% Sell
Avg holding period · 18 Days

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX →

About T-Rex 2X Long MSTR Daily Target ETF

MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on MSTU →